ArticleFrontiers in plant science2026
Comparison of two carbohydrate-based biostimulant complexes for their ability to enhance
Article in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: Two biostimulant complexes were compared by randomised controlled trial (RCT), within an environmentally controlled hydroponic growth system, for their effects on cannabis growth, yield, and flower quality. The two complexes tested were: BC1 comprising molasses, Results and Discussion: Both treatments improved yield (BC1: 1.17-fold, p = 0.097; BC2: 2.22-fold, p = 0.003), with BC2 also increasing flower size (1.28-fold, p = 0.034). Image analyses indicated that neither treatment substantially impacted flower colour. Near infrared indicated that both treatments increased primary amines and methyl containing hydrocarbons, and that BC2 also increased aromatic hydrocarbons. Volatile analysis indicated that BC1 increased a-terpinolene, borneol, terpineol, and valencene, whilst BC2 increased a-humulene, a-phellandrene, α-terpinene, β-caryophyllene, guaiol, limonene, ocimene, and total terpene content. These terpene changes suggest possible increases to flower relaxing effects (BC1), or anti-inflammatory effects (BC2). Odour prediction identified possible shifts to flower odour profiles, which may be associated with enhanced customer perceptions of quality and value. Overall, this study demonstrates the potential for biostimulants to enhance cannabis yield, phytochemical composition, and associated value.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.